These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 21944974)

  • 1. Molecular pathology of MELAS and L-arginine effects.
    Koga Y; Povalko N; Nishioka J; Katayama K; Yatsuga S; Matsuishi T
    Biochim Biophys Acta; 2012 May; 1820(5):608-14. PubMed ID: 21944974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
    El-Hattab AW; Adesina AM; Jones J; Scaglia F
    Mol Genet Metab; 2015; 116(1-2):4-12. PubMed ID: 26095523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification defect at anticodon wobble nucleotide of mitochondrial tRNAs(Leu)(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
    Yasukawa T; Suzuki T; Ueda T; Ohta S; Watanabe K
    J Biol Chem; 2000 Feb; 275(6):4251-7. PubMed ID: 10660592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MELAS and L-arginine therapy: pathophysiology of stroke-like episodes.
    Koga Y; Povalko N; Nishioka J; Katayama K; Kakimoto N; Matsuishi T
    Ann N Y Acad Sci; 2010 Jul; 1201():104-10. PubMed ID: 20649546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenic A3243G mutation in human mitochondrial tRNALeu(UUR) decreases the efficiency of aminoacylation.
    Park H; Davidson E; King MP
    Biochemistry; 2003 Feb; 42(4):958-64. PubMed ID: 12549915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease.
    Kirino Y; Yasukawa T; Ohta S; Akira S; Ishihara K; Watanabe K; Suzuki T
    Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15070-5. PubMed ID: 15477592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo functional brain imaging and a therapeutic trial of L-arginine in MELAS patients.
    Yoneda M; Ikawa M; Arakawa K; Kudo T; Kimura H; Fujibayashi Y; Okazawa H
    Biochim Biophys Acta; 2012 May; 1820(5):615-8. PubMed ID: 21600268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human mitochondrial leucyl-tRNA synthetase corrects mitochondrial dysfunctions due to the tRNALeu(UUR) A3243G mutation, associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like symptoms and diabetes.
    Li R; Guan MX
    Mol Cell Biol; 2010 May; 30(9):2147-54. PubMed ID: 20194621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquisition of the wobble modification in mitochondrial tRNALeu(CUN) bearing the G12300A mutation suppresses the MELAS molecular defect.
    Kirino Y; Yasukawa T; Marjavaara SK; Jacobs HT; Holt IJ; Watanabe K; Suzuki T
    Hum Mol Genet; 2006 Mar; 15(6):897-904. PubMed ID: 16446307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taurine deficiency and MELAS are closely related syndromes.
    Schaffer SW; Jong CJ; Warner D; Ito T; Azuma J
    Adv Exp Med Biol; 2013; 776():153-65. PubMed ID: 23392880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mitochondrial tRNA(Leu)(UUR) mutation at 3,256 associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).
    Sato W; Hayasaka K; Shoji Y; Takahashi T; Takada G; Saito M; Fukawa O; Wachi E
    Biochem Mol Biol Int; 1994 Aug; 33(6):1055-61. PubMed ID: 7804130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.
    Scaglia F; Northrop JL
    CNS Drugs; 2006; 20(6):443-64. PubMed ID: 16734497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-Arginine Affects Aerobic Capacity and Muscle Metabolism in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) Syndrome.
    Rodan LH; Wells GD; Banks L; Thompson S; Schneiderman JE; Tein I
    PLoS One; 2015; 10(5):e0127066. PubMed ID: 25993630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MELAS: Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes].
    Murakami H; Ono K
    Brain Nerve; 2017 Feb; 69(2):111-117. PubMed ID: 28202819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes.
    Chomyn A; Enriquez JA; Micol V; Fernandez-Silva P; Attardi G
    J Biol Chem; 2000 Jun; 275(25):19198-209. PubMed ID: 10858457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease.
    Kirino Y; Goto Y; Campos Y; Arenas J; Suzuki T
    Proc Natl Acad Sci U S A; 2005 May; 102(20):7127-32. PubMed ID: 15870203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new point mutation at nucleotide pair 3291 of the mitochondrial tRNA(Leu(UUR)) gene in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).
    Goto Y; Tsugane K; Tanabe Y; Nonaka I; Horai S
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1624-30. PubMed ID: 7520241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELAS phenotype associated with m.3302A>G mutation in mitochondrial tRNA(Leu(UUR)) gene.
    Goto M; Komaki H; Saito T; Saito Y; Nakagawa E; Sugai K; Sasaki M; Nishino I; Goto Y
    Brain Dev; 2014 Feb; 36(2):180-2. PubMed ID: 23582502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of mitochondrial tRNALeu(UUR) aminoacylation by some MELAS-associated mutations.
    Hao R; Yao YN; Zheng YG; Xu MG; Wang ED
    FEBS Lett; 2004 Dec; 578(1-2):135-9. PubMed ID: 15581630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The A3243G tRNALeu(UUR) MELAS mutation causes amino acid misincorporation and a combined respiratory chain assembly defect partially suppressed by overexpression of EFTu and EFG2.
    Sasarman F; Antonicka H; Shoubridge EA
    Hum Mol Genet; 2008 Dec; 17(23):3697-707. PubMed ID: 18753147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.